Enliven Therapeutics
ELVN
$23.04
Share price
-3.23%
Change (1 day)
15.20%
Change (1 year)
Categories
Enliven Therapeutics (ELVN) - P/B ratio
P/B ratio as of May 2024 : 4.55
According to Enliven Therapeutics's latest financial reports the company has a price-to-book ratio of 4.55.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Enliven Therapeutics - P/B ratio (from 2023 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.32 | |
| 2022-12-31 | N/A | |
| 2021-12-31 | N/A |